In summary, our data suggested that lnc-MCEI inhibition suppressed ESCC tumorigenesis in vivo and lnc-MCEI mediated the chemosensitivity of ESCC by targeting miR-6759-5p /IGF2/PI3K/AKT axis. The gene discussed is IGF2; the disease is esophageal squamous cell carcinoma.